ProZyme Board Names Dr. Sergey Vlasenko as President

ProZyme Board of Directors has appointed Dr. Sergey Vlasenko as the company's new President. Dr. Vlasenko has over 20 years of experience in the life sciences and clinical diagnostics industries. He is an accomplished senior executive with domestic and international skill sets in global marketing, strategic planning, research and development, and product commercialization. His organizational experience spans from co-founding and growing a start-up business to leading divisional marketing for a multi-billion dollar company. He has a track record of identifying market opportunities, driving innovative product development, launching highly differentiated products and enabling sustainable and profitable growth. Dr. Vlasenko received his M.S. degree in Chemistry and Ph.D. degree in Enzyme Kinetics from Moscow University. He completed the Executive Leadership Program at Haas School of Business, UC Berkeley. Dr. Vlasenko has held a number of varied management positions, most notably as Director of Global Marketing at Bio-Rad Protein Function Division and as Vice President of Molecular Diagnostics and Life Sciences at BCM Diagnostics.